glp 1 reducing inflammation GLP-1 Therapies May Benefit MPN And MDS Patients GLP-1 RAs may lead to

00:07:15 Vickie Danaher When considering GLP-1 meds for weight loss, well also want to tailor the selection based on things like cost and access, the patients other comorbidities, and other medication benefits

Brand-name Rybelsus runs $800-$1,200/month without insurance

As the FDA's shortage list for semaglutide and tirzepatide fluctuated between 2023 and 2025, many brands needed a 503A or 503B compounder to supply GLP-1 agents FDA drug shortage list

Safety information and monitoring during therapy Because CJC-1295 is not FDA-approved for general clinical use, safety monitoring during therapy is especially important